Ke Su
Impact in
- Urology top 5%
- Periodontal Regeneration and Treatments
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Surgery 11
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Pelvic and Acetabular Injuries 3
- Hip and Femur Fractures 2
- Co-authors
- Haisen Zhang (3 shared papers)Hao Liu (1 shared paper)Jun Wang (1 shared paper)Ke Xu (8 shared papers)Hao Chi (6 shared papers)Han Li (9 shared papers)Tao Gu (6 shared papers)Lu Guo (7 shared papers)
- Journals
- Clinical & Translational Oncology (2 papers)Journal of Clinical Oncology (2 papers)Clinical and Experimental Medicine (2 papers)Gene (1 paper)American Journal of Translational Research (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ke Su
36 papers receiving 554 citations
Peers
Comparison fields: 5 of 81
- Urology 86
- Hepatology 86
- Cancer Research 48
- Orthopedics and Sports Medicine 26
- Rheumatology 45
Countries citing papers authored by Ke Su
This map shows the geographic impact of Ke Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Su more than expected).
Fields of papers citing papers by Ke Su
This network shows the impact of papers produced by Ke Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Su. The network helps show where Ke Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 122 | |
| 2 | 2023 | 64 | |
| 3 | 2016 | 41 | |
| 4 | 2022 | 38 | |
| 5 | 2023 | 33 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 32 | |
| 8 | 2023 | 30 | |
| 9 | 2019 | 18 | |
| 10 | 2019 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 14 | |
| 14 | 2017 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2017 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2017 | 5 |
About Ke Su
Ke Su is a scholar working on Hepatology, Surgery, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 41 papers that have together received 559 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Mechanisms and Therapy (5 papers), Pelvic and Acetabular Injuries (3 papers), Lung Cancer Research Studies (2 papers), Periodontal Regeneration and Treatments (2 papers), Hip and Femur Fractures (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Urology (86 citations), Hepatology (86 citations), Cancer Research (48 citations), Orthopedics and Sports Medicine (26 citations) and Rheumatology (45 citations). Ke Su has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Haisen Zhang, Hao Liu, Jun Wang, Ke Xu, Hao Chi, Han Li, Tao Gu, Lu Guo, Yunwei Han and Zhenying Wu. Their work appears in journals such as Clinical & Translational Oncology, Journal of Clinical Oncology, Clinical and Experimental Medicine, Gene and American Journal of Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.